Evidence map›Paper›PMID 39504092›Full record

ArticleEinstein (Sao Paulo, Brazil)2024

Simultaneous embolization of the right portal and hepatic veins before intrahepatic cholangiocarcinoma resection.

Américo Gusmão Amorim, Olival Cirilo Lucena da Fonseca Neto, Raimundo Hugo Matias Furtado, Laécio Leitão Batista, Ludmilla Rodrigues Oliveira Costa, Igor Montenegro Galvão

Abstract readCase Reports
In one paragraph

Article in Einstein (Sao Paulo, Brazil), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Américo Gusmão AmorimHospital Universitário Oswaldo Cruz, Universidade de Pernambuco, Recife, PE, Brazil.ORCID http://orcid.org/0000-0002-2056-1599
Olival Cirilo Lucena da Fonseca NetoHospital Universitário Oswaldo Cruz, Universidade de Pernambuco, Recife, PE, Brazil.ORCID http://orcid.org/0000-0002-2383-8610
Raimundo Hugo Matias FurtadoHospital Universitário Oswaldo Cruz, Universidade de Pernambuco, Recife, PE, Brazil.ORCID http://orcid.org/0000-0002-4456-4161
Laécio Leitão BatistaHospital Universitário Oswaldo Cruz, Universidade de Pernambuco, Recife, PE, Brazil.ORCID http://orcid.org/0000-0001-5081-2689
Ludmilla Rodrigues Oliveira CostaFaculdade de Ciências Médicas de Pernambuco, Universidade de Pernambuco, Recife, PE, Brazil.ORCID http://orcid.org/0000-0001-7137-4323
Igor Montenegro GalvãoFaculdade de Ciências Médicas de Pernambuco, Universidade de Pernambuco, Recife, PE, Brazil.ORCID http://orcid.org/0000-0003-0648-4790

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Major liver resections require extensive margins. Occasionally, insufficient parenchyma is available after surgery to maintain liver function. In such cases, vascular embolization in the affected lobe is necessary to induce contralateral lobe hypertrophy. We present a case of embolization of the right portal and hepatic veins prior to intrahepatic cholangiocarcinoma resection. Embolization was performed because of insufficient residual parenchyma on imaging studies. The patient recovered well with no signs of liver failure, and remains in remission at 3 years postoperatively. Knowledge of the use of this technique in association with surgical resection can reduce postoperative complications and allow the removal of larger tumors than those previously considered borderline.

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaEmbolization, TherapeuticHepatectomyHepatic VeinsPortal VeinHumansMaleMiddle AgedTreatment Outcome

Identifiers

PMID39504092
PMCPMC11634352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.